TRCT
BIVV

Tower Research Capital (TRC)’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Tower Research Capital (TRC)’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-565
Closed -$31K – 4267
2017
Q4 		$31K Buy
565
+403
+249% +$22.1K ﹤0.01% 1729
2017
Q3 		$9K Buy
+162
New +$9.49K ﹤0.01% 3139

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Tower Research Capital (TRC)'s BIVV Position: Q1 2018 in Review

Tower Research Capital (TRC) sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 565 shares — an estimated $31K sold.

Tower Research Capital (TRC) first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $31K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Tower Research Capital (TRC) reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 565 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $31K.
  • Tower Research Capital (TRC) first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Bioverativ Inc. Common Stock position peaked at $31K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.